My team is pursuing multiple therapeutic modalities, including therapies using FDA-approved drugs (drug repurposing), combination therapies, new small molecules, and stem cell-based therapy combined with genome editing. I am also working hard to create platforms to bring these new therapies to patients. Both should happen simultaneously.
Thank you for reading this blog. I feel something wonderful is going to happen to us today.
Warmest regards,
Fumi Urano
